Clinical Trials Browser

Phase EARLY_PHASE1 × Mesothelioma × Clear all

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT02748798 2024-10-15

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Phase EARLY_PHASE1 Terminated

10 enrolled

Other solid neoplasmThoracic

Asbestosis, Asthma, Bronchiectasis, Cystic Fibrosis, Emphysema, Rhinitis, Allergic, Seasonal, Hypertension, Pulmonary, Lung Neoplasms, Mesothelioma, Pulmonary Embolism, Pulmonary Fibrosis, Lung Diseases, Interstitial, Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive

NCT04489862 2020-07-28

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

10 enrolled

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT04056026 2019-09-23

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

Phase EARLY_PHASE1 Completed

1 enrolled

Other solid neoplasmThoracic

Mesothelioma